NCT02655328CompletedPhase 4
Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and Doping
University Hospital, Toulouse2 sites in 1 country14 target enrollmentStarted: March 2009Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Enrollment
- 14
- Locations
- 2
- Primary Endpoint
- impact of exercise on pharmacokinetics profile
Study Overview
Brief Summary
This study will determine the pharmacokinetic profile of the salbutamol concentration in the urine while athletes are resting or during exercise.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •patient who hold a license in a sport federation, and do at least 8 hours of sport each week
- •asthmatic patient
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
impact of exercise on pharmacokinetics profile
Time Frame: 4 days
impact of exercise on pharmacokinetics profile of salbutamol concentration in urine
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Unknown
Not Applicable
Physiological Response to Salbutamol and ExerciseHealthyNCT03902106University of Copenhagen40
Withdrawn
Not Applicable
Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?Sports Drug AbuseNCT04402658Norwegian School of Sport Sciences
Completed
Phase 4
Salbutamol, Pharmacogenetics and Breathing MechanicsBronchoconstrictionInhaled SalbutamolCycling PerformanceNCT01903785University of British Columbia94
Unknown
Phase 4
Concentrations of Salmeterol in Blood and UrineAsthmaNCT00914901Bispebjerg Hospital30
Completed
Not Applicable
Pharmacogenetic of Salbutamol in Pediatric Asthma CrisisAsthmaNCT02195258Hôpital Necker-Enfants Malades95